Congenital adrenal hyperplasia (CAH) is an inherited recessive disorder of adrenal steroidogenesis caused by mutations in the steroid 21-hydroxylase gene (CYP21) in more than 90% of affected patients. The CYP21 gene is located within the HLA complex locus on chromosome 6 (6p2l.3). During a molecular characterisation study of a group of 47 Mexican families with 21-hydroxylase deficiency, we identified nine in which the mutation or mutations found in the patient did not appear to originate from one ofthe parents. Through DNA fingerprinting, paternity was established in all nine families with a probability of non-paternity in the range of 109 to 1023. Among these families, we identified one patient with exclusive paternal inheritance of all eight markers tested on chromosome 6p, despite normal maternal and paternal contributions for eight additional markers on three different chromosomes.
ity of non-paternity in the range of 109 to 1023. Among these families, we identified one patient with exclusive paternal inheritance of all eight markers tested on chromosome 6p, despite normal maternal and paternal contributions for eight additional markers on three different chromosomes.
We did not identify duplication of paternal information for markers in the 6q region, consistent with lack of expression of transient neonatal diabetes owing to genomic imprinting in this patient.
Our results substantiate evidence for the existence of different genetic mechanisms involved in the expression of this recessive condition in a substantial portion (-19%) of affected Mexican families. In addition to the identification of a patient with paternal uniparental disomy, the occurrence of germline mutations may explain the unusual pattern of segregation in the majority of the remaining eight families. (7 Med Genet 1998; 35:1014 -1019 Keywords: congenital adrenal hyperplasia; germline mutations; isodisomy; non-mendelian inheritance Steroid 2 1-hydroxylase deficiency is the most common defect leading to congenital adrenal hyperplasia, a recessively inherited disorder that affects adrenal steroidogenesis.' The disease is characterised by varying signs ofvirilisation with or without an inability to retain sodium as a consequence of impaired aldosterone synthesis. The severe "classical form" is present in about 1 in 14 000 liveborns in the general population,2 whereas the prevalence of the attenuated "non-classical form" is calculated to occur in 1 in 100 people in some populations including eastern European Jews.3
Two highly homologous genes located within the HLA class III region on chromosome 6 encode the 21-hydroxylase enzyme: CYP21 is an active gene while CYP21P is a pseudogene that carries several deleterious mutations. The CYP21 gene and its pseudogene share 98% sequence identity. 4 6 Molecular genetic analysis in patients has shown that most of the mutations found in CYP21 are normally present in the pseudogene,7-'0 implying that mutations are transferred from the pseudogene to the functional gene through recombination.7 " We have performed mutation analysis in a group of 47 Mexican CAH families.'2 Among them, we identified nine families in which one of the parents did not carry the mutation or mutations found in the patient. Through genotyping analysis, we found a case of paternal isodisomy of chromosome 6p, which appears to account for the disease in this patient.
Materials and methods
Forty-seven unrelated 2 AG,AC   24  23  1  0  2  F  SW  1 d   HP,AG   ND  ND  ND  ND  3  F  SV  7 d  AG  26  27  1  0  4  M  SV  5y  PP  18  21  1  0  5  F  SV  8y   HS,ABE,HP   17  26  3  1  6  F  SW  5d  AG  17  19  1  0  7  F  SV  5y  ABE,HP,AG  25 Once a point mutation was identified in the patient, confirmation of segregation of each mutation was sought by studying both parents. For DNA fingerprinting analysis, allelic frequencies for each marker were determined in 15 unrelated Mexican subjects. The probability of random coincidence (PRC) (the probability that two unrelated subjects share the same genotype) was calculated through the product of the relative allelic frequencies of each allele in every subject for each marker according to Berumen et aL.l The summation of PRC reflects the probability that two unrelated subjects share identical genotypes at different loci and therefore represents the probability of non-paternity (E PRC values obtained for each parent are shown in fig 1) .
To assess erroneous typing owing to selective amplification of mutated alleles when looking for mutations at the intron 2 region, as has Table 3 Chromosomal location of markers usedfor DNA fingerprinting analysis and sequence of the corresponding amplification primers. The chromosomal location of microsatellite markers usedfor DNA fingerprinting is indicated as well as the sequence of the amplification primers condition in approximately 20% of the families performed studied. 12 rent 
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We found an unexpectedly high frequency of ent sets of obligate carriers in whom no mutation was ,C/F from detected in DNA from blood samples. Through DNA fingerprinting, paternity was established uniparental in all nine families in which no corresponding 9, genotyp-segregation was found (figs 1 and 2). Having )n chromo-confirmed paternity, at least three different at and both genetic mechanisms can be postulated to rimers used account for this observation: (1) the presence of mosaicism in the carrier (possibly in the gonad), i, both par-(2) the occurrence of uniparental disomy imily 9 was (UPD), and (3) the existence of germline mutate chromo-tions. the proceAmong these nine families, we found one y cells were patient with a 46,XX normal karyotype (I.2, acytes from family 9, fig 2) , in whom the disease is apparently the result of paternal uniparental isodisomy of chromosome 6. She displayed homozygosity for one paternal allele for all characteri-eight markers tested on chromosome 6p
[milies with (exclusive paternal haplotype) despite normal itified nine paternal and maternal contributions for eight ats did not additional markers located on three different ound in the chromosomes (chromosomes 1 1, 12 , and 20) y represent (fig 2) . In families 1, 3, 6, 7, and 8 where there s were car-was only one parent available, uniparental dis-1L6pez-Gutierrez, Riba, Ordoiez-Sinchez, et al omy cannot be ruled out owing to the unavailability of the second parent, who is assumed to be heterozygous (fig 1) . Hence, UPD could account for at least 2% of the cases of 21-hydroxylase deficiency in our population.
UPD has been described as a genetic mechanism resulting in the expression of other recessive disorders, such as cystic fibrosis,'6 rod monochromacy," and recently in a patient with Herlitz junctional epidermolysis bullosa.'8 Additionally, paternal isodisomy for chromosome 6 has been described in a patient with a complete deficiency of the fourth component of complement,'9 in a newborn with methylmalonic acidaemia, agenesis of pancreatic beta cells, and diabetes,20 and in three unrelated patients with neonatal transient diabetes.2' 22 It has been proposed that the transient neonatal diabetes (TNDM) in these patients is the result of the expression of an imprinted gene mapped to chromosome 6q22-q23.2' Genotyping of markers on 6q showed that the duplication in the patient in family 9 did not involve the long arm of chromosome 6, which is consistent with the lack of expression of transient neonatal diabetes in this person. This is the first report of a paternal UPD involving only the short arm of chromosome 6. Since the patient did not have any malformations or other pathological conditions besides 21-hydroxylase deficiency, it is possible that the short arm of chromosome 6 does not carry imprinted genes whose altered expression results in disease.
Spence et a!23 proposed three mechanisms leading to UPD. The fact that the patient showed heterozygosity for markers on the long arm of chromosome 6 (fig 2) , sharing alleles with the mother for at least three markers (D6S300, D6S1671, and D6S473), suggests that the mechanism by which the UPD occurred was through the fertilisation by the paternal disomic gamete of a maternal normal one, leading to a trisomy that was corrected to disomy by non-disjunction, after recombination occurred betweeen the maternal and paternal chromosomes 6. It has been postulated that segments around breakpoints of translocations and inversions are prone to duplications, implying that people carrying translocations may be at higher risk of transmitting a duplicated chromosomal region.
Translocations of chromosome 15 have been observed in patients and carriers of Angelman and Prader-Willi syndromes.24 25 However, we did not find alterations at the cytogenetic level in any of the people studied from family 9. According to the incidence of aneuploidy in spontaneous abortions, it has been estimated that around 1/3000 conceptuses may be diploid as a consequence of aneuploid gamete complementation.26 Therefore, the frequency of UPD may be underestimated in patients carrying autosomal recessive disorders since recognition of UPD cases requires, in addition to homozygosity, the expression of additional phenotypic features as a result of genomic imprinting and/or molecular analysis in the patient and his family. The identification of UPD in our patient was through investigation for paternity, since she lacked any additional clinical signs that could be attributed to genomic imprinting.
Although the presence of germline mutations cannot be experimentally proven, it has been shown that de novo mutations in the CYP21 gene are generated in a relatively high proportion of cells (in the order of 1 in 103-1o6 ) in sperm derived from normal subjects.27 Both gene conversion and unequal crossing over events are responsible for the generation of mutated alleles through recombination. It is interesting that in seven of the nine families where no corresponding segregation was found, it was the mother who lacked the mutation found in the patient. Increased recombination frequency has been documented to occur in females at several loci, including the H-2 locus on chromosome 6 in mice,28 the pericentric region of chromosome 21,29 and nearly the entire chromosome 3 in humans."0 This observation is in agreement with the mother being the putative carrier of the germline mutation in the majority of these families.
It is also interesting that in only one of the families where we found this phenomenon is there a second affected child (family 5) (table 1), providing further support for the possibility of germline mutations in the majority of the affected families. In family 5, where only one of the two responsible mutations has been found, the El mutation (CCGG-CTG P30L) was not detected in either parent (fig 1) . The existence of a second affected sib in this family could be the result of a gonadal mosaic cell line in one of the parents.
A similar frequency of apparent germline mutations (20%) has been reported in patients with 21-hydroxylase deficiency in the Japanese population,'0 suggesting that some populations may be at higher risk for the occurrence of these events.
It has been reported that allele drop out can occur during PCR while amplifying the intron 2 region of the CYP21 gene, leading to incorrect genotyping (for example, asymptomatic heterozygous carriers have been typed as homozygous for the intron 2 mutation ).14 Segregation analysis in the affected family using microsatellite markers near the 21-hydroxylase locus is useful in determining both paternal and maternal inheritance of the corresponding alleles. Using this strategy, we proved that patients A2, B2, F2, and G2 (from fig 1) , typed as homozygous for the intron 2 mutation (and having only this mutation), inherited one allele from the parent typed as a non-carrier of the mutation (analysis of genetic markers on 6p2l.3, fig 1) . Moreover, the intron 2 region of the CYP2 1 gene was analysed using three independent PCR reactions generated from different sets of amplification primers (primer pairs A/B, A/D, and C/F from table 2). This procedure is expected to reduce the possibility of selective allele amplification owing to the presence of sequence polymorphisms located in the primer annealing site.
The identification of families with an unexpected pattern of transmission will undoubtedly contribute to a better understanding of the genetic mechanisms involved in the expression of this disorder and will lead to better genetic counselling for these affected families, since the risk of having a second affected child is expected to change dramatically depending upon the mechanism by which the mutation is transmitted.
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